EP0444033A1 - Preparation pharmaceutique et cosmetique topique - Google Patents

Preparation pharmaceutique et cosmetique topique

Info

Publication number
EP0444033A1
EP0444033A1 EP89906773A EP89906773A EP0444033A1 EP 0444033 A1 EP0444033 A1 EP 0444033A1 EP 89906773 A EP89906773 A EP 89906773A EP 89906773 A EP89906773 A EP 89906773A EP 0444033 A1 EP0444033 A1 EP 0444033A1
Authority
EP
European Patent Office
Prior art keywords
acid
acid esters
tocopherol
tocopherols
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP89906773A
Other languages
German (de)
English (en)
Inventor
Siegfried Wallat
Hermann Hensen
Hans Pfeiffer
Achim Ansmann
Hinrich Möller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP0444033A1 publication Critical patent/EP0444033A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Definitions

  • the present invention relates to topical cosmetic and pharmaceutical preparations containing fatty substances and free tocopherols, which can be used to care for the skin and hair.
  • alpha-tocopherol acetate is added as a physiological active ingredient in skin and nutritional creams, oils, masks and bath preparations, especially for the treatment of the aging skin, cosmetic and pharmaceutical preparations.
  • Other tocopherol esters, such as tocopheroinicotinate, are used as active ingredients in medicated hair lotions.
  • tocopherols and their esters are said to promote blood circulation in the skin, have a connective tissue strengthening and cell renewal effect and bring about a better utilization of the oxygen in the tissue.
  • the tocopherol esters described above are stable to oxygen and light, so that they are widely used today in topical cosmetic and pharmaceutical preparations.
  • free tocopherols such as, for example, tizs alpha-tocopherol, or mixed tocopherols from the alpha-, beta-, gamma- and delta-l somers are substances which are not resistant to light and oxygen, so that the use of the free tocopherols in cosmetic and pharmaceutical preparations So far, this is not possible, since this quickly changes under the influence of air and light discolor, are unsightly and cannot be sold in this form.
  • BE 899 975 (Stiefel Lab., Corresponds to EP 147 446) describes an emulsion-like topical composition against psoriasis which contains, inter alia, 0.02% ascorbyl palmitate, 0.9% citric acid and 0.03% alpha-tocopherol.
  • DE-OS 35 in 724 (Jereb) relates to pharmaceutical ointments which contain, inter alia, 1.0% by weight of vitamin C and 0.3% by weight of alpha-tocopherol in a petroleum jelly or Eucerin base.
  • Ronoxan A 25% ascorbyl palmate, 5% D, L-alpha-tocopherol, 0.8% citric acid, 1%
  • the object of the present invention is to provide topical cosmetic and pharmaceutical preparations containing fatty substances and free tocopherols, which have very good color stability to light and air.
  • This object is achieved by the use of free tocopherols in combination with ascorbic acid esters and mono- / diglyceride-citric acid esters as components of these topical compositions based on conventional fat and oil components.
  • the invention therefore relates to topical cosmetic and pharmaceutical preparations containing fatty substances and free tocopherols, which are characterized in that for color stabilization, ascorbic acid esters of fatty acids with 12 to 18 carbon atoms and citric acid esters of partial glycerides of fatty acids with 12 to 20 carbon atoms - are included.
  • ascorbic acid esters and citric acid esters according to the invention it is possible to stabilize the free tocopherols in the topical cosmetic and pharmaceutical preparations to the extent that products are obtained whose color stability is comparable to the quality of corresponding commercial preparations which contain tocopherol esters such as tocopherol acetate.
  • Free tocopherols in the sense of this invention are understood to mean either the pure D-alpha-tocopherol, the D, L-alpha-tocopherol or the corresponding D-mixed tocopherol concentrates of natural origin, as are obtained, for example, from edible oils. These are mixtures of the D-alpha, the D-beta, the D-gamma and the D-delta homologues of tocopherol.
  • the fatty acid portion can consist of saturated and / or unsaturated aliphatic or cycloaliphatic fatty acids. These are, for example, lauric acid, trtdecanoic acid, myristic acid, pentadecanoic acid, palmitic acid, heptadecanoic acid, stearic acid, oleic acid, linoleic acid and linolenic acid or mixtures of these fatty acids, as are obtained from animal or vegetable oleochemical starting materials.
  • the ascorbyl palmitate is preferably used as the ascorbic acid ester.
  • the fatty acid fraction can consist of saturated and / or unsaturated aliphatic fatty acids. These are, for example, lauric acid, tridecanoic acid, myristic acid, pentadecanoic acid, palmitic acid, heptadecanoic acid, stearic acid, nonadecanoic acid, arachidic acid, oleic acid, linoleic acid or linolenic acid or mixtures of these fatty acids, as obtained from animal or vegetable oleochemical starting materials, which may have been hydrogenated beforehand.
  • saturated and / or unsaturated aliphatic fatty acids are, for example, lauric acid, tridecanoic acid, myristic acid, pentadecanoic acid, palmitic acid, heptadecanoic acid, stearic acid, nonadecanoic acid, arachidic acid, oleic acid, linoleic acid or linolenic acid or mixtures of these fatty acids,
  • the mono- / diglyceride-ctronic acid esters are prepared, for example, by esterification of mono- / D ⁇ glycerides with citric acid or by esterification of glycerol with citric acid and fatty acids.
  • These citric acid esters usually have a citric acid content of 13 to 50% by weight, preferably 17 to 22% by weight, a free fatty acid content of less than 3% by weight and a free glycerol content of less than 2% by weight. -% and a bound glycerol content of 18 to 20% by weight.
  • Products of this type are marketed under the names LAMEGI N ZE 30 (Grünau) and TEGl NC (Th. Goldschmidt) distributed. They are also often called "Citrem".
  • the content of free tocopherols in the topical cosmetic and pharmaceutical preparations according to the invention is preferably 1 to 10% by weight.
  • the content of the ascorbic acid ester and the citric acid ester is preferably 0.1 to 10% by weight. -%, based on the amount of tocopherol used.
  • Ultraviolet radiation filter substances ie UV-A radiation filters, UV-B radiation filters or UV-A / UV-B radiation filters, can be added as further components to the topical preparations according to the invention.
  • Suitable ultraviolet radiation filter substances are the paraaminobenzoic acid derivatives known to the person skilled in the art, benzimidazole derivatives, benzophenone derivatives, benzoxazole derivatives, camphor derivatives, coumarin derivatives, dibenzoylmethane derivatives, gallic acid derivatives, salicylic acid derivatives and cinnamic acid or. Paramethoxycinnamic acid derivatives. These are, for example. n-amino benzoic acid, 3- (n-trimethylammonium) benzylidenebbornan-2-one-methylsulfate, 3, 3, 5-trimethyl-cyclohexylsalicylate,
  • UV absorbers are the following products, which are sold under the trademark Eusolex (R) (Merck, Darmstadt) or Parsol
  • topical cosmetic and pharmaceutical preparations according to the invention have been formulated in the following examples only for a lip care stick (with sun protection). However, it is self-evident for the person skilled in the art that other topical preparations can also be formulated in the same way, which also have very good color stability. These topical formulations are furthermore, in particular, bath preparations, skin and hair detergents, skin care products, skin cleansing agents, insect repellants, foot care products, acne agents, agents for treating insect repellent, shaving aids, hair care products and sunscreen preparations.
  • Cetyl alcohol 1.9 parts by weight of beeswax, 2.8 parts by weight of micro wax, 5 parts by weight of myristyl lactate and 5 parts by weight of myristyl myristate are heated and dissolved. The mixture is then allowed to cool to 75 ° C. and the substances listed in the tables below are stirred into this melt (fat base) and this mass is poured into molds.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Des préparations pharmaceutiques et cosmétiques topiques renfermant des graisses et des tocophérols libres et de préférence des substances qui filtrent la lumière ultraviolette, contiennent également, pour stabiliser la couleur, des esters d'acide ascorbique, d'acides gras avec 2 à 18 atomes de C et des esters d'acide citrique de glycérides partielles d'acides gras avec 12 à 20 atomes de C. De préférence, la teneur en tocophérols libres est de 1 à 10 % en poids de la préparation, la teneur en esters d'acide ascorbique et la teneur en esters d'acide citrique étant de 0,1 à 10 % en poids rapportés à la quantité totale de tocophérols.
EP89906773A 1988-06-18 1989-06-09 Preparation pharmaceutique et cosmetique topique Pending EP0444033A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3820693A DE3820693A1 (de) 1988-06-18 1988-06-18 Topische kosmetische und pharmazeutische zubereitungen
DE3820693 1988-06-18

Publications (1)

Publication Number Publication Date
EP0444033A1 true EP0444033A1 (fr) 1991-09-04

Family

ID=6356783

Family Applications (2)

Application Number Title Priority Date Filing Date
EP89110452A Ceased EP0347664A1 (fr) 1988-06-18 1989-06-09 Compositions cosmétiques et pharmaceutiques pour application topique
EP89906773A Pending EP0444033A1 (fr) 1988-06-18 1989-06-09 Preparation pharmaceutique et cosmetique topique

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP89110452A Ceased EP0347664A1 (fr) 1988-06-18 1989-06-09 Compositions cosmétiques et pharmaceutiques pour application topique

Country Status (8)

Country Link
EP (2) EP0347664A1 (fr)
JP (1) JPH03505089A (fr)
KR (1) KR900701249A (fr)
AU (1) AU3760789A (fr)
DD (1) DD283930A5 (fr)
DE (1) DE3820693A1 (fr)
DK (1) DK296690D0 (fr)
WO (1) WO1989012437A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102659A (en) 1990-07-12 1992-04-07 Shaklee Corporation Natural antioxidant compositions
GB9109965D0 (en) * 1991-05-07 1991-07-03 Unilever Plc Cosmetic composition
DE4128748A1 (de) * 1991-08-29 1993-03-04 Beiersdorf Ag Kosmetische stifte
NL9201438A (nl) * 1992-08-11 1994-03-01 Prospa Bv Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen.
DE4343264A1 (de) * 1993-12-17 1995-06-22 Henkel Kgaa Deodorierende Zubereitungen
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
DE19529773A1 (de) * 1995-08-12 1997-02-13 Beiersdorf Ag Hautpflegemittel und pflegendes Hautreinigungsmittel
JPH11199425A (ja) * 1998-01-05 1999-07-27 Nippon Haipokkusu:Kk 化粧料
DE19802206A1 (de) 1998-01-22 1999-07-29 Beiersdorf Ag Lipidreduzierte, fließfähige Zubereitungen
DE19802204A1 (de) * 1998-01-22 1999-07-29 Beiersdorf Ag Kosmetische oder pharmazeutische Zubereitungen mit vermindertem Klebrigkeitsgefühl, enthaltend Glycerinester von -Hydroxycarbonsäuren und gesättigten Fettsäuren
AU746555B2 (en) 1998-10-30 2002-05-02 Kabushiki Kaisha Toshiba Apparatus for controlling synchronous motor
DE19933670A1 (de) * 1999-07-17 2001-01-18 Beiersdorf Ag Verwendung von kosmetischen oder dermatologischen Zubereitungen zur Stabilisierung von Ascorbinsäure und/oder Ascorbylverbindungen
DE10031324A1 (de) * 2000-07-03 2002-01-17 Henkel Kgaa Stabilisiertes kosmetisches Mittel
JP4091746B2 (ja) * 2001-02-06 2008-05-28 日清オイリオグループ株式会社 紫外線吸収物質の安定性向上のための使用、紫外線吸収剤及び化粧料

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK136039B (da) * 1970-09-08 1977-08-01 Kongo Yakuhin Kabushiki Kaisha Fremgangsmåde og middel til at forhindre oxydation af lipider og/eller farvestoffer, som indgår eller skal indgå i næringsmidler.
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
DE3522572C2 (de) * 1984-03-07 1997-07-03 Roshdy Ismail Verwendung von Vitamin E zum Schutz der Haut
US4711894A (en) * 1986-01-16 1987-12-08 Henkel Corporation Stabilized tocopherol in dry, particulate, free-flowing form
FR2610626B1 (fr) * 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8912437A1 *

Also Published As

Publication number Publication date
DK296690A (da) 1990-12-13
KR900701249A (ko) 1990-12-01
DE3820693A1 (de) 1989-12-21
DK296690D0 (da) 1990-12-13
EP0347664A1 (fr) 1989-12-27
DD283930A5 (de) 1990-10-31
JPH03505089A (ja) 1991-11-07
AU3760789A (en) 1990-01-12
WO1989012437A1 (fr) 1989-12-28

Similar Documents

Publication Publication Date Title
DE69325896T2 (de) Ungesättigte Fettsäure-Triglyceride enthaltende Lipidzusammensetzung für Kosmetik
DE69201510T2 (de) Verwendung von Lysin und/oder Arginin Pyrrolidone-Carboxylate als Antioxidationsmittel in Kosmetika oder Pharmazeutika.
DE69201216T2 (de) Öllösliche Antioxydationsmischung.
EP0343694B1 (fr) Agent pour le traitement et la protection de la peau
US5653966A (en) Lipid composition for cosmetic products
DE4100490C1 (fr)
EP0444033A1 (fr) Preparation pharmaceutique et cosmetique topique
DE69933518T2 (de) Stabile flüssige zusammensetzungen von kalzium-ascorbat und verfahren zu ihrer herstellung und verwendung
DE69720737T2 (de) Pflanzliche ölzusammensetzungen
DE69322912T2 (de) Kosmetisches und/oder Nahrungsmittel enthaltend eine nicht-verseifbare Fraktion von Sesamöl und Vitamin-E
EP0804150B1 (fr) Lotions contenant des derives d'acide gras
DE2734823C2 (de) Sonnenschutzmittel
DE1492149A1 (de) Masse zur Behandlung und zur Pflege der Haut
EP0911016B1 (fr) Utilisation d'esters d'ascorbyl de l'acide phosphorique pour stabiliser le vitamine a et/ou les derivatives de vitamine a dans des compositions cosmetique et pharmaceutique
DE4223463A1 (de) Kosmetisches Pflegemittel gegen lichtbedingte Hautalterung
DE69114796T2 (de) Antioxydantsystem auf Basis einer basischen Aminosäure und eines Tocopherols.
DE60106014T2 (de) Verwendung von n,n'-dibenzylethylendiamindiessigsäurederivaten zum schutz gegen verschmutzung
EP1216694A1 (fr) Combinaisons d'esters d'acide citrique tensioactifs et d'acide lipoique, ainsi que preparations cosmetiques et dermatologiques contenant de tels melanges
DE69713896T2 (de) Pharmazeutische formulierungen zur topischen verwendung mit vit. e acetate
JP7507864B2 (ja) 向上した安定性を有するビタミンａおよびビタミンｃの組み合わせ
JPH03200708A (ja) 皮膚外用剤
DE10355711A1 (de) Kosmetische und dermatologische Emulsionen, enthaltend Kreatin und/oder Kreatinin und Elektrolytkonzentrationen, einer Ionenstärke von mindestens 50 mmol/l
DE10013167A1 (de) Verwndung eines Schutzsystems zur Stabilisierung von Ascorbinsäure in kosmetischen und pharmazeutischen Zubereitungen
EP1576948A2 (fr) composition anhydre contenant des colorants polaires
RU2005471C1 (ru) Крем для кожи лица

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 19901128

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

XX Miscellaneous

Free format text: VERFAHREN ABGESCHLOSSEN INFOLGE VERBINDUNG MIT 89110452.3/0347664 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) VOM 27.11.91.